arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 12/2016 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    THERAPY FROM A CRITICAL VIEWPOINT

    Celecoxib (CELEBREX, generics) - as safe as naproxen and ibuprofen regarding cardiovascular events?

    Prevention of thromboembolism after knee arthroscopy or lower-leg casting

    Rivaroxaban for patients with atrial fibrillation undergoing placement of stents: doubtful benefits compared with warfarin

    a-t READERS QUESTIONS AND COMMENTS

    Adjuvanted flu vaccine FLUAD … clinical efficacy benefits still not proven
    free

    Carotis plaques detected by screening in healthy people - what should you do?

    Restrict package size for colchicine preparations

    IN BRIEF

    USA: warning notice for homoeopathics

    Pfizer/UK: 100 million € fine because of high prices

    CURRENT ADR NETWORK REPORT

    Angioedema and other intolerance reactions with oral lavendula oil (LASEA)

    SIDE EFFECTS

    Unusual coloured urine due to drugs

    e a-t ON THE INTERNET

    Hepatitis C: sofosbuvir plus velpatasvir (EPCLUSA

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles